DEBRA MAGEE: Open Payments
NPI 1396886149 · WYTHEVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,057 in 93 payments from 10 companies in 2025. Trend: 2023 $1,858 · 2024 $1,716 · 2025 $2,057
Food & beverage: $1,946Education: $111
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 16 | $444 |
| Teva Pharmaceuticals USA, Inc. | 27 | $436 |
| Alkermes, Inc. | 17 | $296 |
| Neurocrine BioSciences, Inc. | 13 | $289 |
| Otsuka America Pharmaceutical, Inc. | 6 | $262 |
| Janssen Pharmaceuticals, Inc | 8 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $90 |
| Lundbeck LLC | 2 | $38 |
| ABBVIE INC. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
Products named: COBENFY, ARISTADA, INGREZZA, REXULTI, AUSTEDO XR, SPRAVATO, UZEDY, CAPLYTA.
Industry payments across VA — which companies pay providers there.
